Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|April 7, 2018
Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicityM Fuertes, M Sapochnik, L Tedesco, et al.
European Journal of Endocrinology|June 12, 1999
Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenomaT Skorić, M Korsić, K Zarković, et al.
International Journal of Peptide and Protein Research|September 1, 1993
Synthesis and in vitro activities of new tryptophan-modified and thiomethylene-containing pseudopeptide antagonists of the neurokininsJ Paladino, C Thurieau, A D Morris, et al.
Gynecologic Oncology|June 16, 2018
Use of a web-based app to improve postoperative outcomes for patients receiving gynecological oncology care: A randomized controlled feasibility trialIlana Graetz, Janeane N Anderson, Caitlin N McKillop, et al.
Journal of Neurosurgery|June 1, 1995
Extended anterior subcranial approach for skull base tumors: long-term resultsJ Raveh, J B Turk, K Lädrach, et al.
Lijecnicki Vjesnik|December 4, 2001
[Importance of the CRH (corticotropin releasing hormone) test in the differential diagnosis of Cushing's syndrome]M Korsić, V Plavsić, N Besenski, et al.
European Journal of Endocrinology|November 18, 2000
Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulationI Pentz-Vidovíc, T Skorić, G Grubisić, et al.
Journal of Pediatric Psychology|August 25, 2021
Nocturnal Enuresis in Sickle Cell: Sociodemographic, Medical, and Quality of Life FactorsJerlym S Porter, Andrew J Paladino, Kathryn Russell, et al.
BMC Health Services Research|November 24, 2022
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancerAndrew J Paladino, Kinsey Pebley, Mehmet Kocak, et al.
Drug Design and Discovery|November 1, 1994
Estimation of blood levels of endothelin and neurokinin receptor antagonists at the rat portal and jugular veins after oral administration as a tool in peptide drug designJ Paladino, N Kucharczyk, A D Morris, et al.
Pageof 4